Position in HLN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$200
-$2 QoQ
Shares Held
20
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Anfield Capital Management, LLC holds $9,625 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #4 (2.1% of the industry book) .
All Filings in HLN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $200 | 20 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $202 | 20 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $179 | 20 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,379 | 133 | Shares | Defined | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||